Our technology gives failed drug molecules a second chance.

Nanoform set to globalize its technology with appointment of a Chief Commercial Officer

PRESS RELEASE 29 October 2018 Nanoform set to globalize its technology with appointment of a Chief Commercial Officer Helsinki, Finland – Nanoform, a Helsinki, Finland-based drug particle engineering and nanotechnology company, is set to globalize its novel nanonization technology with the appointment of Christian Jones as Chief Commercial Officer. The newly created role is imperative …

Nanoform set to globalize its technology with appointment of a Chief Commercial OfficerRead More »

Nanoform set to transform drug development through €7 million investment in patented nanoparticle technology

PRESS RELEASE 19 September 2018 Nanoform set to transform drug development through €7 million investment in patented nanoparticle technology Helsinki, Finland – Nanoform, an innovative drug particle engineering and nanotechnology company that provides novel API particle-size reduction services, is continuing its strategic growth through a significant €7 million investment, with Vator Securities acting as the …

Nanoform set to transform drug development through €7 million investment in patented nanoparticle technologyRead More »